Success Stories from MAT Participants: Real Recovery Journeys

Medically reviewed by Dr. Richard A. Marasa, MD, MBA — Board Certified in Addiction Medicine, Emergency Medicine & Internal Medicine | Medical Director, Clear Steps Recovery

Key Takeaways

• MAT reduces non-fatal overdose risk by nearly 60% among justice-involved individuals compared to those not receiving treatment.
• High abstinence rates at 12 months — Studies show MAT participants maintain sobriety from illicit opioids well beyond the first year of enrollment.
• Comprehensive care matters — The most successful MAT programs combine FDA-approved medications with individual counseling, group therapy, and discharge planning.
• Community-level impact — MAT programs reduce post-incarceration drug use, criminal behavior, mortality, and HIV risk behaviors across entire communities.
• Participant voices drive improvement — Feedback from MAT participants has led to better staff training, more recovery services, and earlier discharge planning.

What Is Medication-Assisted Treatment?

Medication-Assisted Treatment (MAT) combines FDA-approved medications — such as buprenorphine, methadone, and naltrexone — with counseling and behavioral therapies to treat opioid use disorder. Unlike detox alone, MAT addresses both the physical and psychological dimensions of addiction, giving people a stronger foundation for long-term recovery.

The success stories below come from published research on MAT programs across the United States, demonstrating how this evidence-based approach changes lives.

Achievements and Milestones in Recovery

Participants in MAT programs consistently report reaching milestones that once seemed impossible. Across clinical studies, individuals describe regaining stable housing, rebuilding family relationships, returning to work, and setting meaningful personal goals — from furthering their education to simply being present for their children.

These achievements are not abstract. A Utah-based MAT program that served insured, underinsured, and uninsured individuals in Davis, Weber, and Morgan counties demonstrated high rates of abstinence from illicit substances at 12 months post-enrollment. Participants in this program received FDA-approved medications alongside counseling from a clinical team that included a treating physician, registered nurse, and licensed clinical social worker.

Measured Benefits of MAT Programs

Research confirms what participants experience firsthand. In a Rhode Island Department of Corrections MAT program, participants reported:

• Reduced withdrawal symptoms during treatment
• Decreased use of illicit drugs within the facility
• An improved overall environment for all residents
• Stronger motivation to continue MAT after release

These benefits extend far beyond individual recovery. Providing MAT access in correctional settings has been shown to reduce post-incarceration illicit opioid use, criminal behavior, mortality, overdose risk, and HIV risk behaviors — benefiting entire communities.

How MAT Reduces Overdose Risk

One of the most compelling findings comes from a systematic review of 20 studies representing 30,119 participants. Justice-involved individuals receiving MAT had nearly a 60% reduced odds of experiencing a non-fatal overdose compared to those not receiving treatment.

This statistic is critical. Opioid overdose remains one of the leading causes of death among people recently released from incarceration. MAT provides a pharmacological bridge that stabilizes brain chemistry, reduces cravings, and dramatically lowers the risk of a fatal or near-fatal event during the highest-risk period of recovery.

What Participants Say About Their Treatment

The most valuable insights come from the people in treatment themselves. Across multiple studies, MAT participants have consistently asked for:

More Recovery Services

Participants want access to a wider range of support — individual counseling, structured group meetings, educational workbooks, and diverse programming that addresses the full scope of recovery beyond medication alone.

Better-Trained Staff

Feedback highlights the importance of educating all staff members — including correctional officers and nursing staff — on how MAT works, its clinical benefits, and the nature of addiction as a medical condition. When staff understand the treatment, the care environment improves for everyone.

Earlier Discharge Planning

Participants consistently emphasize the need for early access to information about post-release MAT options and community-based treatment. Connecting people to outpatient care before they leave a facility helps maintain recovery momentum and reduces the risk of relapse during transition.

Community-Level Impact of MAT Programs

MAT programs that use a collective impact approach — bringing together healthcare providers, community organizations, and local government — have been especially effective at expanding access to underserved populations. The Utah program, for example, placed specific emphasis on serving pregnant women and individuals experiencing or at risk of homelessness.

When communities invest in MAT access, the results are measurable: lower overdose rates, reduced emergency room visits, fewer re-incarcerations, and healthier families. These outcomes demonstrate that MAT is not just a clinical intervention — it is a public health strategy.

Getting Help with MAT at Clear Steps Recovery

At Clear Steps Recovery, our Medication-Assisted Treatment programs are led by Dr. Richard A. Marasa, MD, MBA, who brings over 40 years of clinical experience and 21 years of personal recovery to his work with patients. Our programs combine FDA-approved medications with individual counseling, group therapy, and comprehensive discharge planning — the same evidence-based components shown in the research above to produce the best outcomes.

Whether you or a loved one is struggling with opioid addiction, our team is ready to help you take the first step toward lasting recovery.

New Hampshire: (603) 769-8981 | Londonderry, NH Location

Massachusetts: (781) 765-0001 | Needham, MA Location

Learn more about our approach in our guide to Understanding MAT for Opioid Addiction and Recovery with Medication-Assisted Treatment.

Sources

• National Center for Biotechnology Information. (2023). Medication-assisted treatment in correctional settings: Participant perspectives. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347877/
• National Center for Biotechnology Information. (2020). Expanding access to medication-assisted treatment through a collective impact approach. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751497/
• National Center for Biotechnology Information. (2022). Medication-assisted treatment and justice-involved populations: A systematic review. PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742132/
• Substance Abuse and Mental Health Services Administration (SAMHSA). Medication-Assisted Treatment (MAT). https://www.samhsa.gov/medications-substance-use-disorders